第 33 届 TRI-CON 将邀集高级投资者、制药公司高管、企业家、研究思想领袖和创新者。您将可在亲密互动单元和投资者及合作伙伴交流，并透过产业主导的小组讨论，深入了解诊断、精准医疗和人工智慧领域的融资、业务拓展和创新策略，同时也可在活跃的炉边谈话中听取 KOL 的坦诚见解和商业建议。TRI-CON 拥有超过 30 年的经验，是主要利害关系人加深有意义的人脉、获取宝贵策略见解并推动创新与合作的首选平台。让我们2026年旧金山再见！
2025 Featured Speakers
Mara Aspinall
Partner
Illumina Ventures
Peter Foley
CEO
LetsGetChecked
Lisa Alderson
CEO
Adela
Gabriele Allegri
VP, Global Commercial Precision Medicine
Johnson & Johnson
Alex Aravanis
CEO
Moonwalk Biosciences
Omar Perez
Head of Medical Diagnostics
AstraZeneca
Jenny Rooke
Managing Director
Genoa Ventures
Ajit Singh
Partner
Artiman Ventures
Susan Tousi
CEO
DELFI Diagnostics
Steffan Ho
VP, Translational Oncology
Pfizer
Lourdes Barrera
Executive Director, Precision Medicine
Merck
Christopher Conn
Director, Diagnostics Strategy
Amgen
Andrea L. Stevens
Senior Director
Precision Medicine Access, Johnson & Johnson
Ezra Cohen
CMO, Oncology
Tempus Labs
Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health
Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi
Edward Abrahams
Former President
Personalized Medicine Coalition
Kyle Farh
VP, Artificial Intelligence Lab
Illumina
Howard Scher
Head, Biomarker Development Program
Memorial Sloan Kettering Cancer Center
Shawn Carlson
Vice President, Head of Market Access
Roche Diagnostics
Friends of TRI-CON,
历届TRI-CON精彩回顾
